Neuberger Berman Group
NRC icon

Neuberger Berman Group’s NRC Health Common Stock NRC Stock Holding History

Neuberger Berman Group’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,109
Closed -$219K – 2168
2025
Q3 		$219K Sell
17,109
-10,833
-39% -$162K ﹤0.01% 1877
2025
Q2 		$469K Sell
27,942
-1,303
-4% -$17.6K ﹤0.01% 1596
2025
Q1 		$374K Buy
29,245
+4,466
+18% +$71.7K ﹤0.01% 1626
2024
Q4 		$437K Sell
24,779
-5,148
-17% -$97.6K ﹤0.01% 1558
2024
Q3 		$684K Sell
29,927
-659
-2% -$14.9K ﹤0.01% 1414
2024
Q2 		$702K Buy
30,586
+2,348
+8% +$72.4K ﹤0.01% 1384
2024
Q1 		$1.12M Sell
28,238
-1,928
-6% -$76.3K ﹤0.01% 1257
2023
Q4 		$1.19M Buy
30,166
+14,385
+91% +$602K ﹤0.01% 1437
2023
Q3 		$700K Buy
15,781
+652
+4% +$28.5K ﹤0.01% 1360
2023
Q2 		$658K Buy
15,129
+85
+0.6% +$3.74K ﹤0.01% 1363
2023
Q1 		$655K Sell
15,044
-1,079
-7% -$47.6K ﹤0.01% 1375
2022
Q4 		$601K Sell
16,123
-684
-4% -$26.5K ﹤0.01% 1390
2022
Q3 		$668K Sell
16,807
-1,040
-6% -$38.5K ﹤0.01% 1382
2022
Q2 		$683K Sell
17,847
-2,110
-11% -$76.3K ﹤0.01% 1406
2022
Q1 		$792K Sell
19,957
-505,557
-96% -$19.8M ﹤0.01% 1405
2021
Q4 		$21.8M Sell
525,514
-446,551
-46% -$19.4M 0.02% 671
2021
Q3 		$41M Sell
972,065
-12,099
-1% -$609K 0.04% 513
2021
Q2 		$45.2M Sell
984,164
-32,907
-3% -$1.57M 0.04% 491
2021
Q1 		$47.6M Sell
1,017,071
-2,939
-0.3% -$143K 0.05% 444
2020
Q4 		$43.6M Sell
1,020,010
-22,512
-2% -$1.16M 0.05% 429
2020
Q3 		$51.3M Sell
1,042,522
-25,983
-2% -$1.44M 0.06% 365
2020
Q2 		$62.2M Buy
1,068,505
+1,054
+0.1% +$55.7K 0.08% 326
2020
Q1 		$48.5M Buy
1,067,451
+8,913
+0.8% +$535K 0.07% 332
2019
Q4 		$69.8M Buy
1,058,538
+28,582
+3% +$1.75M 0.08% 334
2019
Q3 		$59.5M Buy
1,029,956
+766,183
+290% +$47.5M 0.07% 351
2019
Q2 		$15.2M Buy
263,773
+238,305
+936% +$11M 0.02% 671
2019
Q1 		$983K Sell
25,468
-3,076
-11% -$121K ﹤0.01% 1123
2018
Q4 		$1.09M Sell
28,544
-809
-3% -$31.1K ﹤0.01% 1102
2018
Q3 		$1.13M Sell
29,353
-451
-2% -$17.1K ﹤0.01% 1155
2018
Q2 		$1.12M Sell
29,804
-642
-2% -$22.4K ﹤0.01% 1198
2018
Q1 		$891K Sell
30,446
-13,812
-31% -$463K ﹤0.01% 1217
2017
Q4 		$1.68M Sell
44,258
-14,226
-24% -$505K ﹤0.01% 1059
2017
Q3 		$2.2M Sell
58,484
-153
-0.3% -$4.81K ﹤0.01% 976
2017
Q2 		$1.58M Buy
58,637
+545
+0.9% +$13.3K ﹤0.01% 1054
2017
Q1 		$1.14M Buy
58,092
+438
+0.8% +$8.1K ﹤0.01% 1122
2016
Q4 		$1.1M Buy
57,654
+7,620
+15% +$126K ﹤0.01% 1114
2016
Q3 		$815K Buy
50,034
+7,630
+18% +$120K ﹤0.01% 1158
2016
Q2 		$581K Sell
42,404
-4,208
-9% -$59.3K ﹤0.01% 1213
2016
Q1 		$725K Buy
46,612
+8,027
+21% +$118K ﹤0.01% 1171
2015
Q4 		$619K Buy
+38,585
New +$586K ﹤0.01% 1220

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QV Investors
QV Investors Calgary, Alberta, Canada $1.36B AUM 20.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Neuberger Berman Group's NRC Position: Q4 2025 in Review

Neuberger Berman Group sold out of NRC Health Common Stock (NRC) in Q4 2025, closing a stake of 17,109 shares — an estimated $219K sold.

Neuberger Berman Group first reported a position in NRC in Q4 2015 and held it in 40 quarters. The position peaked at $69.8M in Q4 2019. 117 funds tracked by Wall St. Rank hold NRC as of Q4 2025.

  • Neuberger Berman Group reported no remaining NRC Health Common Stock position as of Q4 2025 after selling out during the quarter.
  • Neuberger Berman Group sold 17,109 NRC Health Common Stock shares in Q4 2025, an estimated $219K.
  • Neuberger Berman Group first reported a position in NRC Health Common Stock in Q4 2015 and held it in 40 quarters.
  • Neuberger Berman Group's NRC Health Common Stock position peaked at $69.8M in Q4 2019.
  • 117 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q4 2025.

Based on Neuberger Berman Group's 13F filing for Q4 2025, filed 13 Feb 2026.